Community Cancer Care Linked with Poorer Outcomes for Patients with a Common Head and Neck Cancer
https://reachmd.com/news/community-cancer-care-linked-with-poorer-outcomes-for-patients-with-a-common-head-and-neck-cancer/2456734/
FOR IMMEDIATE RELEASENewswise — Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community cancer centers, but patients treated in this setting may be less likely to survive, according to new resear…
A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
https://reachmd.com/news/a-type-of-allergy-medicine-might-help-treat-lung-cancer-research-suggests/2456702/
New York, NY (December 06, 2023) Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small …
Regenex Bio Eyes FDA Meeting to Confirm Pivotal DMD Trial
https://reachmd.com/news/regenex-bio-eyes-fda-meeting-to-confirm-pivotal-dmd-trial/2463008/
Regenex Bio has announced it is meeting with the US Food and Drug Administration (FDA) with plans to initiate a pivotal trial of its Duchenne muscular dystrophy (DMD) gene therapy candidate before the end of this year. The US-based biotech is looking to investigate its gene therapy candidate RGX-2…
Lurie Children’s Hospital First-in-Pediatrics to Use Technology That Lights Up Lung Cancer During Surgery
https://reachmd.com/news/lurie-childrens-hospital-first-in-pediatrics-to-use-technology-that-lights-up-lung-cancer-during-surgery/2462924/
Ann & Robert H. Lurie Children’s Hospital of Chicago is pleased to announce the first pediatric use of the novel fluorescent agent CYTALUX during surgery to remove lung metastases. The drug allows surgeons to better visualize cancer in the lung, as well as potentially detect additional cancerous n…
Vaccine Found to Target Multiple Strains
https://reachmd.com/news/vaccine-found-to-target-multiple-strains/2462844/
Vaccines have revolutionized the way we preemptively protect against disease. The concept of vaccination was first demonstrated by Dr. Edward Jenner in the 19th century who found that exposing an individual to cowpox, an attenuated version of smallpox, protected…
Bariatric Surgery-Induced Upregulation of apoA-IV Is Beneficial for Insulin Secretion and Energy Expenditure: Study
https://reachmd.com/news/bariatric-surgery-induced-upregulation-of-apoa-iv-is-beneficial-for-insulin-secretion-and-energy-expenditure-study/2462774/
by Frontiers Journals Credit: Lynn Greyling/public domain …
Study Reveals Crucial Insights into the Ocular Effects of Zika Virus Infection During Pregnancy
https://reachmd.com/news/study-reveals-crucial-insights-into-the-ocular-effects-of-zika-virus-infection-during-pregnancy/2462728/
A groundbreaking study published in the journal iScience presents crucial insights into the ocular effects of Zika virus infection during pregnancy and offers promising avenues for therapeutic intervention. Produced by a team of researchers in the Department of Ophthalmology, Visua…
Laboratory Model Enables Researchers to Explore the Mouth's Response to Oral Disease
https://reachmd.com/news/laboratory-model-enables-researchers-to-explore-the-mouths-response-to-oral-disease/2462512/
Credit: Unsplash/CC0 Public Domain Researchers have created a three-dimensional model of the oral mucosa that can be used in studies to test its response to a range of bacterial and other infections. …
Larger Trials Needed to Evaluate Intermittent Fasting for MS: Review
https://reachmd.com/news/larger-trials-needed-to-evaluate-intermittent-fasting-for-ms-review/2462513/
An intermittent fasting (IF) diet may lead to immune and metabolic alterations that ease multiple sclerosis (MS) symptoms and improve quality of life, a recent review of published studies suggests. While evidence from these few small clinical trials indicate an IF diet might help manage “this int…
Inflammation-Reducing Drug Shows No Benefit for Dry Age-Related Macular Degeneration in NIH Trial
https://reachmd.com/news/inflammation-reducing-drug-shows-no-benefit-for-dry-age-related-macular-degeneration-in-nih-trial/2462387/
Newswise — The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI), part of the National…